Skip to content

LeMaitre Vascular LMAT Share Buybacks

Share Buybacks at other companies

ITG
Integer HoldingsITGR
$50M
Haemonetics logo
HaemoneticsHAE
$100M-33.3%
Abbott logo
AbbottABT
$180M-35.7%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$2B
Edwards Lifesciences logo
Edwards LifesciencesEW
$421.8M+63.1%
Medtronic logo
MedtronicMDT
$435M+58.8%

Other financials

Income statement

See full
Revenue$66.6M+11.2%
Gross profit$48.4M+16.8%
Operating income$17.8M+40.8%
Net income$15.7M+42.4%
EPS (diluted)$0.68+41.7%

Balance sheet

See full
Cash & equivalents$26.9M+6.0%
Total debt$20.9M+20.6%
Total equity$406.6M+17.0%
Total assets$629.5M+13.2%

Cash flow

See full
Operating cash flow$15.1M+67.0%
CapEx$2.8M+101%
Free cash flow$12.3M+60.8%

Valuation

See full
Market cap$2.1B+31.4%
Enterprise value$2.1B+31.6%
P/E33.7×-1.7×
P/S8.2×+1.1×

Profitability

See full
Gross margin72.4%+3.6pp
Operating margin28.5%+5.1pp
Net margin24.3%+4.4pp
FCF margin30.9%+12.7pp

Returns & leverage

See full
Return on equity16.5%+2.8pp
Debt / equity0.1×0.0×
Current ratio14.3×-2.2×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LeMaitre Vascular's share buybacks?
LeMaitre Vascular (LMAT) reported share buybacks of $460K in Q1 2026.
How has LeMaitre Vascular's share buybacks changed year-over-year?
LeMaitre Vascular's share buybacks decreased by 23.5% year-over-year, from $601K to $460K.
What is the long-term trend for LeMaitre Vascular's share buybacks?
Over 3 years (2022 to 2025), LeMaitre Vascular's share buybacks has grown at a 41.6% compound annual growth rate (CAGR), from $642K to $1.82M.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.